[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:acute-leukemia-of-ambiguous-lineage":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":107,"states":120},"Acute Leukemia of Ambiguous Lineage",16,[7,15,22,28,34,40,46,52,58,64,71,77,83,89,95,101],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06177067","Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia",[11],"Phase 1","RECRUITING","2026-08-26T02:19:29.119921Z","2026-05-05T02:43:27.978998Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06317662","Testing the Addition of the Anti-cancer Drug Venetoclax and\u002For the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia",[19],"Phase 2","2026-08-26T02:17:58.890423Z","2026-05-05T02:43:27.976183Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT06803745","Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT)",[],"2026-08-26T02:19:28.327680Z","2026-05-05T02:43:28.866353Z",{"nct_id":29,"title":30,"phases":31,"status":12,"updated_at":32,"content_modified":33},"NCT06575296","Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant",[11],"2026-08-26T02:18:40.612983Z","2026-05-05T02:43:27.843378Z",{"nct_id":35,"title":36,"phases":37,"status":12,"updated_at":38,"content_modified":39},"NCT04375631","CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia",[11],"2026-08-26T02:16:22.235886Z","2026-05-05T02:43:26.964811Z",{"nct_id":41,"title":42,"phases":43,"status":12,"updated_at":44,"content_modified":45},"NCT07046078","Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer",[19],"2026-08-26T02:19:25.538428Z","2026-05-05T02:35:31.876787Z",{"nct_id":47,"title":48,"phases":49,"status":12,"updated_at":50,"content_modified":51},"NCT03826992","Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia",[11],"2026-08-26T02:18:53.782384Z","2026-05-05T02:43:29.669276Z",{"nct_id":53,"title":54,"phases":55,"status":12,"updated_at":56,"content_modified":57},"NCT05292664","Venetoclax Basket Trial for High Risk Hematologic Malignancies",[11],"2026-08-26T02:17:39.857430Z","2026-05-05T02:43:29.646005Z",{"nct_id":59,"title":60,"phases":61,"status":12,"updated_at":62,"content_modified":63},"NCT06807606","Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation",[19],"2026-08-26T02:17:30.961790Z","2026-05-05T02:43:29.132814Z",{"nct_id":65,"title":66,"phases":67,"status":12,"updated_at":69,"content_modified":70},"NCT04988555","A Phase 1\u002F2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)",[68],"Phase 1\u002FPhase 2","2026-08-26T02:16:33.772093Z","2026-05-05T02:43:28.989174Z",{"nct_id":72,"title":73,"phases":74,"status":12,"updated_at":75,"content_modified":76},"NCT04959903","Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT",[68],"2026-08-26T02:15:30.699880Z","2026-05-05T02:43:27.631001Z",{"nct_id":78,"title":79,"phases":80,"status":12,"updated_at":81,"content_modified":82},"NCT04065399","A Study of Revumenib in R\u002FR Leukemias Including Those With an MLL\u002FKMT2A Gene Rearrangement or NPM1 Mutation",[68],"2026-08-26T02:18:48.678868Z","2026-05-05T02:43:27.111185Z",{"nct_id":84,"title":85,"phases":86,"status":12,"updated_at":87,"content_modified":88},"NCT06397027","A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias",[11],"2026-08-26T02:16:17.877565Z","2026-05-05T02:43:27.100920Z",{"nct_id":90,"title":91,"phases":92,"status":12,"updated_at":93,"content_modified":94},"NCT06013423","Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases",[19],"2026-08-26T02:16:50.548894Z","2026-05-05T02:43:26.947230Z",{"nct_id":96,"title":97,"phases":98,"status":12,"updated_at":99,"content_modified":100},"NCT03633955","Pilot Imaging Study of Leukemia",[11],"2026-08-26T02:15:56.561131Z","2026-05-05T02:43:27.294668Z",{"nct_id":102,"title":103,"phases":104,"status":12,"updated_at":105,"content_modified":106},"NCT07094750","Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms",[],"2026-08-26T02:17:03.534765Z","2026-07-19T19:36:05.065181Z",[108,112,116],{"biomarker":109,"count":110,"slug":111},"KMT2A Gene",5,"kmt2a-gene",{"biomarker":113,"count":114,"slug":115},"NPM1 Gene",4,"npm1-gene",{"biomarker":117,"count":118,"slug":119},"NUP98 Gene",3,"nup98-gene",[121,125,128,131,134,137,140,143,146,149,152,155,158,161,164,167,170],{"state":122,"count":123,"slug":124},"California",6,"california",{"state":126,"count":123,"slug":127},"Texas","texas",{"state":129,"count":110,"slug":130},"Colorado","colorado",{"state":132,"count":110,"slug":133},"Georgia","georgia",{"state":135,"count":110,"slug":136},"New York","new-york",{"state":138,"count":110,"slug":139},"Ohio","ohio",{"state":141,"count":110,"slug":142},"Washington","washington",{"state":144,"count":114,"slug":145},"Illinois","illinois",{"state":147,"count":114,"slug":148},"Massachusetts","massachusetts",{"state":150,"count":114,"slug":151},"Pennsylvania","pennsylvania",{"state":153,"count":118,"slug":154},"District of Columbia","district-of-columbia",{"state":156,"count":118,"slug":157},"Florida","florida",{"state":159,"count":118,"slug":160},"Maryland","maryland",{"state":162,"count":118,"slug":163},"Missouri","missouri",{"state":165,"count":118,"slug":166},"New Jersey","new-jersey",{"state":168,"count":118,"slug":169},"North Carolina","north-carolina",{"state":171,"count":118,"slug":172},"Tennessee","tennessee"]